Ocular Therapeutix Inc

Stock Chart, Company Information, and Scan Results

$11.38(as of Jul 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ocular Therapeutix Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$11.38
Ticker SymbolOCUL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees274
CountyUSA
Market Cap$1,766.6M
EBIDTA-201.8M
10-Day Moving Average10.51
P/E Ratio-9.89
20-Day Moving Average9.68
Forward P/E Ratio0.00
50-Day Moving Average8.58
Earnings per Share-1.11
200-Day Moving Average8.56
Profit Margin-602.34%
RSI75.47
Shares Outstanding159.3M
ATR0.53
52-Week High11.78
Volume2,123,326
52-Week Low5.79
Most Recent Support Level10.92
Book Value265.9M
Most Recent Resistance Level11.47
P/B Ratio7.17
Upper Keltner10.86
P/S Ratio31.98
Lower Keltner8.49
Debt-to-Equity Ratio10.86
Next Earnings Date08/11/2025
Cash Surplus311.8M
Next Ex-Dividend DateUnknown

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and in Phase 1 clinical trials for the treatment of non-proliferative diabetic retinopathy; PAXTRAVA, a travoprost intracameral hydrogel, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and PAXTRAVA. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Ocular Therapeutix Inc In Our Stock Scanner

example chart graphic
Date: Jul 17, 2025Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
example chart graphic
Date: Jul 17, 2025Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Date: Jul 17, 2025Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 17, 2025Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 17, 2025Scan Name: Low Debt with 20%+ Return on EquityScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.